Tci Wealth Advisors, Inc. Haemonetics Corp Transaction History

Tci Wealth Advisors, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$63.3 - $78.66 $189 - $235	3 Added 1.45%	210 $16,000
Q1 2022 Apr 29, 2022	BUY	$43.77 - $63.22 $8,184 - $11,822	187 Added 935.0%	207 $13,000
Q4 2021 Jan 24, 2022	SELL	$49.55 - $74.59 $5,549 - $8,354	-112 Reduced 84.85%	20 $1,000
Q3 2021 Oct 29, 2021	SELL	$57.6 - $70.59 $691 - $847	-12 Reduced 8.33%	132 $9,000
Q2 2021 Aug 02, 2021	BUY	$51.81 - $118.56 $6,424 - $14,701	124 Added 620.0%	144 $10,000
Q4 2018 Jan 17, 2019	SELL	$90.66 - $116.63 $725 - $933	-8 Reduced 28.57%	20 $2,000
Q3 2018 Nov 02, 2018	SELL	$89.96 - $114.58 $1,439 - $1,833	-16 Reduced 36.36%	28 $3,000
Q2 2018 Jul 27, 2018	BUY	$71.53 - $95.75 $1,716 - $2,298	24 Added 120.0%	44 $4,000
Q2 2017 Aug 10, 2017	BUY	N/A	20	20 $1,000

333

54M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.21B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.